Regencell Bioscience Holdings (RGC) Shares Issued (2022)
Regencell Bioscience Holdings' (RGC) quarterly Shares Issued came in at $301085.0 in Q2 2022.
Analysis
Regencell Bioscience Holdings (RGC) Shares Issued (2022) Analysis & Trends
Regencell Bioscience Holdings (RGC) has reported Shares Issued for 1 consecutive years, with $301085.0 the latest figure, recorded in Q2 2022.
- For the quarter ending Q2 2022, Shares Issued changed N/A year-over-year to $301085.0; the trailing twelve-month figure through Jun 2022 stood at $301085.0 (changed N/A YoY), and the FY2022 full-year result was $301085.0, changed N/A from the prior year.
- Shares Issued was little changed at $301085.0 in Q2 2022 per RGC's latest filing.
- Across five years, Shares Issued topped out at $301085.0 in Q2 2022 and bottomed at $301085.0 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | - |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | - |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Regencell Bioscience Holdings | 75.87 Mn | 73.51 Mn | - | - |